AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Outcome of the Treatment of Flexor Tendon Injuries

Recruitingn/aAges 18 Years - 75 YearsAllUniversity of Zurich
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

In order to gather enough data for meaningful statistics, a multicenter register of all flexor tendon repairs was established with surgical, clinical and rehabilitation patient data. The controlled active motion (CAM) protocol was administered in all patients after surgery. The purpose was to (i) measure surgery and therapy outcomes in the three centers and (ii) evaluate potential influencing factors on outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Injury between 2014 and 2025 * Flexor tendon injury of the fingers or thumb in zones 1-3 Exclusion Criteria: * No given consent * Concomitant injuries as fractures, large soft tissue injuries, replantation * Bony avulsion fracture of flexor tendon (Jersey finger) * Basic disease as rheumatoid diseases * Primary and secondary tendon reconstruction and tendon transfer
๐Ÿ’Š

What it tests

  • Controlled active motion (CAM)
๐Ÿ“

Where

1 site
University Hospital Zurich, Clinic of Reconstructive Surgery
Zurich, Switzerland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy